| Gene symbol | CT83 | Synonyms | CXorf61, KK-LC-1, KKLC1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq23 | dbXrefs | |
| Description | cancer/testis antigen 83 | ||||
| GTO ID | GTC2783 |
| Trial ID | NCT05035407 |
| Disease | Stomach Cancer | Epithelial Cancer | Lung Cancer | Cervical Cancer | Breast Cancer |
| Altered gene | KK-LC-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | KK-LC-1 TCR-T cells |
| HLA | HLA-A*01:01 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase I Trial of T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers |
| Year | 2021 |
| Country | United States |
| Company sponsor | National Cancer Institute (NCI) |
| Other ID(s) | 10000045|000045-C |
| Cohort 1 | |||||||||||
|
|||||||||||